Dublin, Sept. 25, 2013 (GLOBE NEWSWIRE) -- Research and Markets
(http://www.researchandmarkets.com/research/gvmgpq/telemedicine_the)
has announced the addition of the
"Telemedicine: The Future is Now for Moving Telemedicine into
Mainstream Treatment" report to their offering.
Telemedicine is a creation of the 20th century. First used
primarily for military and space applications, it has been becoming
more widespread in use in recent years. There are three main types
of telemedicine applications: store-and-forward, remote monitoring
and interactive services.
Interest in telemedicine is growing globally, particularly in the
fields of teleradiology, telepathology and teledermatology.
Globally, cost is seen as the major barrier to telemedicine
programs. In the US, telemedicine has been promoted as a way to
serve rural populations, but in the next few years it is expected
to spread to a much wider patient base.
A number of key challenges still need to be addressed for the use
of telemedicine to become more widespread in the US. Licensing and
reimbursement remain major hurdles to physician participation in
telemedicine.
These challenges are being addressed at the state level, with an
increasing number of state legislatures taking up the issues. There
is also federal legislation being looked at by Congress. Issues of
FDA Regulation and possible issues of taxation also need to be
clarified to help promote wider use of telemedicine.
The report,
Telemedicine - The Future is Now for Moving Telemedicine into
Mainstream Treatment was written to support both the
biopharmaceutical and health care industries in understanding the
use of telemedicine and preparing for the expected growth it will
see in the coming years.
Key Reasons to Purchase
· This comprehensive study can be used to compare the effectiveness of the different telemedicine applications available CBR's insights and case study analysis
· Companies can assess the impact of health care reform on telemedicine uptake now and in the future
· Gain insights on the key challenges that exist to further expansion of telemedicine programs and how they can be overcome
· Better evaluate the potential for telepharmacy programs, a key area of opportunity for the pharmaceutical industry
· Utilize the insights from this study to analyze the barriers facing wider adoption of telemedicine
Key Topics Covered:
Executive Summary
Chapter 1: Development of Telemedicine
· Development of Telemedicine
· Types of Telemedicine
· Where Telemedicine is being Used
· Expansion of Telemedicine
Chapter 2: Key Challenges to Telemedicine
· Licensing
· Reimbursement
· Legislation
· Regulation
· Taxation
Chapter 3: Case Studies
· Dermatology
· Neurology
· Diabetes
· A UK Study Heart Disease, Diabetes, and COPD
· Elderly Patients
· Intensive Care
· Telepharmacy
Chapter 4: The Outlook for Telemedicine
· The Impact of Health Care Reform
New Technologies
For more information visit
http://www.researchandmarkets.com/research/gvmgpq/telemedicine_the
Research and Markets
Laura Wood, Senior Manager.
U.S. Fax: 646-607-1907